Raphael R.

Raphael R. is a seasoned executive with extensive experience in the biotechnology and investment sectors. Currently serving as CEO and Chairman of the Board of Directors at Antharis Therapeutics, Inc. and Galileo Biotech, Raphael R. has guided the latter company through a successful acquisition by Antharis in 2023. Additionally, Raphael R. holds positions as CEO & Executive Chairman of Pinaud Investments and as a Partner & Portfolio Manager at Leste Global Investments. With a diverse board member role across various organizations, including Cassyni Biopharma and Piauhy Labs, and advisory positions with multiple companies, Raphael R. combines a strong academic background in biomedical engineering, neuroscience, molecular biology, and economics, with degrees from prestigious institutions such as Harvard Business School and Duke University.